Tirzepatide Shortage Resolved; Compounder Sues FDA; Menopause Mistaken as Dementia News and commentary from the endocrinology world Oct 08, 2024
Metabolic Accelerator Shows Promise for Weight Loss Side of Obesity-HFpEF Equation Benefit in symptoms, functional outcomes remains to be seen for HU6 Oct 02, 2024
Drug-Free Obesity Capsule Cleared; FDA Reviews Acromegaly Tx; Stem Cells Reverse T1D News and commentary from the endocrinology world Oct 01, 2024
One-Year CGM Cleared; Osteoporosis Lawsuits Revived; Chemicals and Early Puberty News and commentary from the endocrinology world Sep 24, 2024
GLP-1 Drugs in MASLD Tied to Lower Risk of Cirrhosis, Death Limited benefit seen in patients with established cirrhosis, however Sep 16, 2024
Early Data for GLP-1 Pill; FAERS Tirzepatide Reports; AI Diabetes Voice Screening More noteworthy research from the EASD 2024 meeting Sep 13, 2024
Liraglutide Helped Cut BMI in Kids With Obesity as Young as 6 Saxenda group six times more likely to lose at least 5% of BMI Sep 10, 2024
FreeStyle Libre 3 Sensor Class I Recall; Second OTC CGM Cleared; Weekly Insulin Win News and commentary from the endocrinology world Sep 09, 2024
Meat Types and T2D; Semaglutide in Heart Failure; Acromegaly at the Paralympics News and commentary from the endocrinology world Sep 03, 2024
T1D Stem Cell Success Story; Lilly's Discount Tirzepatide Vials; Stelo Now Available News and commentary from the endocrinology world Aug 27, 2024
Zepbound Can Prevent Diabetes; Menopause and Cognition; Tandem's Insulin Pump Update News and commentary from the endocrinology world Aug 20, 2024
Disposable CGM Approved; Mounjaro Tied to Reduced Mortality; Benefits of Lignins News and commentary from the endocrinology world Aug 13, 2024
Eating Disorders After GLP-1s? Tirzepatide for Heart Failure; Soda Taxes and BMI News and commentary from the endocrinology world Aug 06, 2024
Faulty FreeStyle Libre 3 Sensors; Endocrine Society Merger; More Levemir Pushback News and commentary from the endocrinology world Jul 30, 2024
Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues News and commentary from the endocrinology world Jul 23, 2024
People Without Diabetes Make Up Growing Share of GLP-1 Users Approximately one-fourth of new users in 2023 did not have type 2 diabetes Jul 22, 2024
Few Stick With Ozempic; Pfizer Making Daily GLP-1; Once-Weekly Insulin Turned Down News and commentary from the endocrinology world Jul 16, 2024
New Investigational Fertility Pill; Biden Wants Lower GLP-1 Prices; BVO to Be Banned News and commentary from the endocrinology world Jul 09, 2024
Tirzepatide Bests Semaglutide for Real-World Weight Loss Injectables were compared at doses approved for type 2 diabetes Jul 08, 2024
CAH Drug Under Review; Gender-Affirming Surgery in Kids; CGMs for Non-Diabetics News and commentary from the endocrinology world Jul 01, 2024
First GLP-1 Generic Launched; 5:2 Intermittent Fasting Win; WHO's Ozempic Warning News and commentary from the endocrinology world Jun 25, 2024
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2D Insulin sensitivity also improved in people with obesity free of diabetes Jun 23, 2024
Farxiga OK'd for Kids; Semaglutide Price Hearing; Maintaining GLP-1 Weight Loss News and commentary from the endocrinology world Jun 18, 2024
Two OTC CGMs Cleared; USPSTF Draft Recs for Osteoporosis; Generic Ozempic in Testing News and commentary from the endocrinology world Jun 11, 2024
Bariatric Surgery Linked With Lower Mortality vs GLP-1 Drugs in Study, but ... Analysis of patients with obesity and diabetes only looked at first-generation GLP-1 agonists Jun 07, 2024
ENDO 2024 Roundup: Teen GLP-1 Coverage; Novel CAH Drug; Hot Flash Risks More research from the Endocrine Society's annual meeting Jun 05, 2024
Chinese Herbs for Diabetes Prevention; Long-Term Tepezza Data; Novel Cushing's Tx News and commentary from the endocrinology world Jun 03, 2024
Tirzepatide Sheds Pounds in Chinese Adults With BMI as Low as 24 Percentage weight loss is in line with pivotal trial results using standard obesity thresholds May 31, 2024
How Many Ditch GLP-1 Drugs? More Weekly Insulin Data; Ozempic for Alcohol Use? News and commentary from the endocrinology world May 28, 2024
Wegovy Perks Sustained for Years; Most Have 'CKM Syndrome'; New Adrenal Guidelines News and commentary from the endocrinology world May 14, 2024
Ozempic Price Cut; Hypoparathyroidism Tx Fast Tracked; Halle Berry's Menopause Bill News and commentary from the endocrinology world May 07, 2024
Hypothalamic Obesity Tx; Weekly Insulin Under Review; Ozempic Price Investigation News and commentary from the endocrinology world Apr 30, 2024
New T2D Guidelines; More Cushing's Relacorilant Data; Drug Shortages Rage On News and commentary from the endocrinology world Apr 23, 2024
Brenzavvy vs Farxiga for T2D; PFAS in Seafood; 100 Deaths Linked to GLP-1 Drugs? News and commentary from the endocrinology world Apr 16, 2024
Study Assuages Thyroid Cancer Fears With GLP-1 Receptor Agonists Study findings support conclusions of the European Medicines Agency's recent investigation Apr 10, 2024
Type D Personality and Hypothyroidism; Infertility and eGFR; Fracture Algorithm News and commentary from the endocrinology world Apr 09, 2024
Diabetes Drugs Overpriced; Hormone Drugs and Brain Tumors; Menopause or Herpes? News and commentary from the endocrinology world Apr 02, 2024
Need 10,000 Daily Steps to Prevent Obesity? It May Depend on Genetics Current recommendations may underestimate activity needs for people with high genetic risk Mar 27, 2024
Insulin Out-of-Stock; Yet Another GLP/GIP Agonist; Digital Diabetes Tools Worth It? News and commentary from the endocrinology world Mar 26, 2024
Automated Insulin System OK'd; Zepbound Gains in Popularity; Male Menopause Cures? News and commentary from the endocrinology world Mar 19, 2024
